Preferred Label : Myoclonic epilepsy of unverricht and lundborg;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : ULD; EPM1; Epilepsy, progressive myoclonic, 1a; Progressive myoclonic epilepsy; EPM1A; Baltic myoclonic epilepsy; PME; Epilepsy, progressive myoclonic, 1;
Description : Myoclonic epilepsy of Unverricht and Lundborg is an autosomal recessive disorder characterized
by onset of neurodegeneration between 6 and 13 years of age. Although it is considered
a progressive myoclonic epilepsy, it differs from other forms in that is appears to
be progressive only in adolescence, with dramatic worsening of myoclonus and ataxia
in the first 6 years after onset. The disease stabilizes in early adulthood, and myoclonus
and ataxia may even improve, and there is minimal to no cognitive decline (summary
by Ramachandran et al., 2009). - Genetic Heterogeneity of Progressive Myoclonic Epilepsy
Progressive myoclonic epilepsy refers to a clinically and genetically heterogeneous
group of neurodegenerative disorders, usually with debilitating symptoms, although
severity varies. See also EPM1B (612437), caused by mutation in the PRICKLE1 gene
(608500); Lafora disease (EPM2A/B; 254780), caused by mutation in either the EPM2A
(607566) or the NHLRC1 (608072) gene; EPM3 (611726), caused by mutation in the KCTD7
gene (611725); EPM4 (254900), caused by mutation in the;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the cystatin B gene (CSTB, 601145.0001);
Prefixed ID : #254800;
Origin ID : 254800;
UMLS CUI : C0751785;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)